Maria Lowe: No financial relationships to disclose
Specialty pharmaceuticals represent a rapidly expanding and incredibly diverse subset of prescription drugs. While many specialty pharmaceuticals are often associated with great therapeutic promise, the cost and complexity of these products pose unique challenges for healthcare providers, payers, and policymakers. It has never been more important for managed care professionals to stay ahead in this evolving treatment landscape.
Join this session to learn more about recent specialty approvals, emerging specialty products with potential for near-term approval, and trends within this area of drug development.
Learning Objectives:
At the completion of this activity, participants should be able to:
